BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Pharm Country

  22nd Century Ships 2.4 Million Spectrum Cigarettes for the National Institute on Drug Abuse

  22nd Century has supplied the Company’s proprietary SPECTRUM® research cigarettes for NIDA since 2011.

  November 30, 2017

   · 

  4 min read
• Business

  Merus Announces Third Quarter 2017 Financial Results and Clinical Highlights

  Merus ended the third quarter of 2017 with cash and cash equivalents of €202.4 million compared to €56.9 million at December 31, 2016.

  November 30, 2017

   · 

  10 min read
• Total Number of Shares and Voting Rights in Zealand at November 30, 2017

  The company issues announcements regarding the total number of shares and voting rights in the Company at the end of a calendar month during which there have been changes to its share capital.

  November 30, 2017

   · 

  1 min read
• Bio NC

  Worldwide Clinical Trials Receives First Annual 2017 Medidata Accelerator Award

  Worldwide Clinical Trials has been recognized by Medidata, the leading global provider of cloud-based solutions and data analytics for clinical research, with the first annual Medidata Accelerator Award.

  November 30, 2017

   · 

  3 min read
• Financial Calendar for Zealand Pharma in 2018

  Zealand’s Annual General Meeting will be held on April 19, 2018.

  November 30, 2017

   · 

  1 min read
• Pharm Country

  Johnson & Johnson and Partners Announce First Efficacy Study for Investigational Mosaic HIV-1 Preventive Vaccine

  On the eve of World AIDS Day Johnson & Johnson announced that its Janssen Pharmaceutical Companies together with a consortium of global partners have initiated the first efficacy study for an investigational mosaic HIV-1 preventive vaccine.

  November 30, 2017

   · 

  8 min read
• Policy

  EMA Accepts MAAs for Mylan and Biocon’s Proposed Biosimilars Trastuzumab and Pegfilgrastim

  EMA acceptance of the submissions follows an earlier withdrawal of both applications in response to an audit conducted by the European inspecting authority of Biocon’s drug product facility.

  November 30, 2017

   · 

  7 min read
• Tikcro Technologies Announces 2017 Annual General Meeting

  Tikcro Technologies today announced that its Annual General Meeting of Shareholders will be held on January 4, 2018 at 9:30 a.m. Israel time, at the office of the Company at 7 Sapir Street, Ness Ziona, Israel.

  November 30, 2017

   · 

  1 min read
• 

  Policy

  Adamis Pharmaceuticals Submits Prior Approval Supplement to FDA for the Pediatric Version of Symjepi

  Symjepi Injection 0.3mg is an FDA-approved product, for the emergency treatment of allergic reactions including anaphylaxis, designed for patients weighing 66 pounds or greater.

  November 30, 2017

   · 

  5 min read
• Actions Versus Words: Aurora CEO’s Actions Reveal That Aurora Stock is Inflated; Insiders Sell $17 Million in Stock During Their Hostile Take-over Bid for CanniMed and During a Financing

  Cannimed draws the attention of CanniMed shareholders to the recent sell-off by the CEO, other senior management and directors of Aurora Cannabis of over $17.8 million worth of Aurora shares

  November 30, 2017

   · 

  7 min read